BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2025-01-31
• Last 15 days FTD volume: C$0.03 M
• Last 3 months FTD volume: C$0.12 M
• Last year FTD volume: C$0.12 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	C$1.63 M	C$32.44 M	🇺🇸 USA
Sarepta Therapeutics SRPT	C$5.46 M	C$38.26 M	🇺🇸 USA
NanoViricides NNVC	C$2.59 M	C$5.72 M	🇺🇸 USA
Novavax NVAX	C$18.83 M	C$0.14 B	🇺🇸 USA
Gilead Sciences GILD	C$28.81 M	C$96.29 M	🇺🇸 USA
Celldex Therapeutics CLDX	C$1.59 M	C$6.5 M	🇺🇸 USA
GlaxoSmithKline GSK	C$94.71 M	C$0.14 B	🇬🇧 UK
Emergent BioSolutions EBS	C$1.1 M	C$6.08 M	🇺🇸 USA
Cel-Sci CVM	C$0.59 M	C$2.67 M	🇺🇸 USA